UveitisScleritis and EpiscleritisEndophthalmitisMasquerade SyndromesIntraocular Lymphoma
Investigational drug(s) / intervention(s)
No Intervention: Observational Cohort
No Intervention: Observational Cohort: Not applicable, No intervention. Observational study.
Study summary
This is a retrospective study analyzing demographics, clinical characteristics, treatment received, and outcomes of ocular inflammatory diseases that presented to the Singapore National Eye Centre (SNEC).
Eligibility
Sex
ALL
Min age
21 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients diagnosed with uveitis
* Patients diagnosed with scleritis or episcleritis
* Patients diagnosed with ocular neoplasms e.g., vitreoretinal and uveal lymphoma
* Patients diagnosed with endophthalmitis
* Diagnosis confirmed by laboratory testing or histopathological examination
* Patients diagnosed and managed at the Singapore National Eye Centre (SNEC)
Exclusion Criteria:
* Patients with less than two years of clinical follow-up
* Patients with incomplete diagnostic confirmation (i.e., lacking laboratory or histopathological evidence)
* Patients diagnosed outside of Singapore National Eye Centre (SNEC)
* Cases with missing key clinical or outcome data
Primary outcome measure(s)
Distribution of demographics, diagnosis, clinical features, treatment and outcomes — January 1987 and January 2025 Percentage ethnic distribution, percentage of gender distribution, percentage of age distribution, percentage of etiology, percentage of clinical features, percentage of investigations, percentage of diagnosis, percentage of secondary complications, percentage of treatment received, percentage of outcomes
Trial sites (1)
Facility
City
Region
Status
Singapore National Eye Centre
Singapore
Singapore
More Singapore National Eye Centre trials in Singapore
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.